<DOC>
	<DOCNO>NCT02800473</DOCNO>
	<brief_summary>This study evaluate therapeutic value : ( ) simultaneous endoscopic visualization inner bladder use white light blue light excitation ( ii ) high resolution panoramic image bladder inner wall . All participant undergo fluorescence cystoscopy : first half use first reference medical device fluorescence cystoscopy already market use innovative device specifically developped CyPaM2 project . The half undergo fluorescence cystoscopy use first innovative reference medical device .</brief_summary>
	<brief_title>Validation Endoscopic Bimodal Imager Bladder Cancer Detection</brief_title>
	<detailed_description>An innovative medical device developped CyPaM2 project 's partners.This device make hardware software part : ( ) imager ( light source sensor ) simultaneous colocalized visualisation bladder use white light blue light fluorescence excitation ( ii ) mosaicing software automatic building high-resolution panoramic image bladder inner wall . The medical device 's qualitative ( human engineering , image qualitty ) quantitative ( medical examination panoramic image build duration ) specification evaluate clinical trial comparison reference medical device already market . The main goal achieve ( ) good sensitivity bladder cancer ' cystocopic diagnosis shorter medical examination duration thank simultaneous visualization bladder inner wall white blue light ( ii ) good patient ' follow thanks high resolve panoramic image .</detailed_description>
	<mesh_term>Urinary Bladder Neoplasms</mesh_term>
	<criteria>Age &gt; 18 year Patient suspicion bladder cancer suspect recurrence bladder cancer Cytological bacteriological examination urine culture negative Patient must affiliate social security system Ability provide write informed consent patient 's legal capacity consent study participation understand comply requirement study Age &lt; 18 year Bladder infection progress untreated Hemorrhage Urethral stenosis Contraindication cystoscopy examination Contraindication administration Hexvix ( porphyria , hypersensitivity hexylaminol√©vulinate excipient Hexvix ( disodium phosphate dihydrate , potassium dihydrogen phosphate ) Pregnant breast feeding female Patients deprive liberty supervision</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Bladder cancer</keyword>
	<keyword>Hexvix</keyword>
	<keyword>Bimodal Endoscopic Imager</keyword>
	<keyword>Cystoscopy</keyword>
</DOC>